Cancer Diagnosis Program (CDP)

Cancer Diagnosis Program (CDP)

Omics Tests and Clinical Trials

NCI and academic collaborators have developed 30 criteria to evaluate the readiness of complex molecular tests to guide decision-making during clinical trials. Using mathematical models, these “omics” tests study genes, proteins, and other types of molecules taken from a biological sample. Omics tests potentially can predict which therapies are most likely to be beneficial.

•	Checklist for clinical readiness of omics lab tests
•	NCI’s Cancer Diagnosis Program